PBPH ETF
Portfolio Building Block World Pharma and Biotech Index ETF
LLY is PBPH's largest holding at 15.46% of the fund as of Oct 4, 2026. PBPH is Portfolio Building Block World Pharma and Biotech Index ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | L | Eli Lilly & Co.Health Care · Pharmaceuticals | 15.46% | 15.5% | 138,242 | $157.99M | Health Care | Pharmaceuticals |
| 2 | J | Johnson & Johnson -Health Care · Pharmaceuticals | 9.89% | 25.4% | 394,671 | $101.05M | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 | A | AbbVie Inc. | 7.44% | 32.8% | 289,548 | $76.10M | ||
| 4 | M | Merck & Company Inc | 5.71% | 38.5% | 404,229 | $58.33M | ||
| 5 | — | Roche Ps Par Ag | 4.74% | 43.2% | 116,049 | $48.42M | ||
| 6 | — | AstraZeneca PLC | 4.54% | 47.8% | 294,907 | $46.38M | ||
| 7 | A | Amgen Inc. | 4.29% | 52.1% | 108,736 | $43.82M | ||
| 8 | N | Novartis Ag - Class N | 4.09% | 56.2% | 297,809 | $41.82M | ||
| 9 | G | Gilead Sciences | 3.93% | 60.1% | 277,440 | $40.16M | ||
| 10 | P | Pfizer Inc | 3.47% | 63.6% | 1,276,004 | $35.47M | ||
| 11 | — | Nvaesrtex Pharmaceuticals Inc | 2.79% | 66.3% | 56,596 | $28.57M | ||
| 12 | B | Bristol-Myers Squibb Co. | 2.73% | 69.1% | 457,159 | $27.96M | ||
| 13 | N | Novo Nordisk Class B | 2.62% | 71.7% | 714,035 | $26.80M | ||
| 14 | — | GSK plc | 1.92% | 73.6% | 833,530 | $19.65M | ||
| 15 | S | Sanofi | 1.89% | 75.5% | 241,834 | $19.31M | ||
| 16 | R | Regeneron Pharmaceuticals, Inc. | 1.60% | 77.1% | 22,205 | $16.33M | ||
| 17 | — | Moderna therapeutics | 1.46% | 78.6% | 78,542 | $14.92M | ||
| 18 | — | Csl Ltd | 1.28% | 79.8% | 107,392 | $13.12M | ||
| 19 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | 1.26% | 81.1% | 14,018 | $12.89M | ||
| 20 | N | Natera Inc | 1.22% | 82.3% | 30,321 | $12.44M | ||
| 21 | T | Takeda Pharmaceutical Co. Ltd. Com Stk | 1.22% | 83.5% | 348,871 | $12.49M | ||
| 22 | B | Bayer (Germany) | 1.10% | 84.6% | 221,086 | $11.21M | ||
| 23 | — | Teva Pharmaceutical Industries Limited (Adr) | 1.01% | 85.7% | 259,556 | $10.34M | ||
| 24 | I | Illumina, Inc. | 0.90% | 86.6% | 33,642 | $9.19M | ||
| 25 | R | Revolution Medicines Inc Ser C Pc Pp | 0.81% | 87.4% | 40,041 | $8.27M | ||
| 26 | S | Sandoz Group Ag | 0.74% | 88.1% | 91,482 | $7.57M | ||
| 27 | B | Biogen Inc. | 0.71% | 88.8% | 32,844 | $7.22M | ||
| 28 | — | Otsuka Holdings Co., Ltd. Com Stk | 0.65% | 89.5% | 91,919 | $6.60M | ||
| 29 | A | Alnylam Pharmaceuticals Inc. | 0.64% | 90.1% | 29,791 | $6.55M | ||
| 30 | Z | Zoetis Inc . | 0.63% | 90.7% | 92,466 | $6.44M | ||
| 31 | — | Daiichi Sankyo Co. Ltd. Com Stk | 0.61% | 91.3% | 362,150 | $6.22M | ||
| 32 | — | Ucb Sa | 0.60% | 91.9% | 26,775 | $6.17M | ||
| 33 | — | Astellas Pharma Inc. Com Stk | 0.54% | 92.5% | 387,981 | $5.52M | ||
| 34 | I | Insmed Inc | 0.53% | 93.0% | 49,120 | $5.46M | ||
| 35 | — | Haleon Plc | 0.53% | 93.5% | 1,240,037 | $5.39M | ||
| 36 | — | Chugai Pharmaceutical Co. Ltd. Com Stk | 0.52% | 94.1% | 139,871 | $5.35M | ||
| 37 | I | Incyte Corporation Ltd. | 0.50% | 94.6% | 44,657 | $5.15M | ||
| 38 | U | United Therapeutics Corp | 0.50% | 95.1% | 9,465 | $5.13M | ||
| 39 | R | Royalty Pharma Plc Class A Ordinary Share | 0.49% | 95.6% | 87,619 | $5.01M | ||
| 40 | G | Genmab A/S | 0.44% | 96.0% | 13,291 | $4.53M | ||
| 41 | V | Viatris | 0.43% | 96.4% | 251,819 | $4.43M | ||
| 42 | — | Roivant Sciences Ltd. Common Shares | 0.37% | 96.8% | 106,944 | $3.82M | ||
| 43 | E | Exelixis Inc | 0.33% | 97.1% | 57,598 | $3.36M | ||
| 44 | N | Neurocrine Biosciences Inc | 0.33% | 97.5% | 23,303 | $3.34M | ||
| 45 | J | Jazz Pharmaceuticals Plc. | 0.33% | 97.8% | 14,322 | $3.38M | ||
| 46 | — | Shionogi & Co Ltd | 0.27% | 98.1% | 156,182 | $2.76M | ||
| 47 | R | Roche Holding Ag- Genusschein | 0.27% | 98.3% | 6,515 | $2.80M | ||
| 48 | E | Elanco Animal Health, Inc Cvr | 0.26% | 98.6% | 118,443 | $2.62M | ||
| 49 | B | Biomarin Pharmaceutical Inc. | 0.25% | 98.8% | 45,007 | $2.57M | ||
| 50 | G | Galderma | 0.24% | 99.1% | 12,441 | $2.41M | ||
| More holdings · Pro | ||||||||
PBPH ETF All Holdings
PBPH holdings total 55 positions. The top 10 holdings account for 63.6% of the fund, led by Eli Lilly & Co. at 15.5%, Johnson & Johnson - Common at 9.9%, Abbvie Inc. at 7.4%.
PBPH portfolio concentration is relatively high, with the top 10 representing 63.6% of total assets. The largest sector exposure is Health Care at 71.6%.
PBPH sectors provide a detailed breakdown. PBPH overlap shows how holdings compare to other funds in your portfolio.
PBPH ETF Holdings
56 of 55 holdings
- 1
Eli Lilly & Co.
LLYHealth Care15.46% - 2
Johnson & Johnson - Common
JNJHealth Care9.89% - 3
Abbvie Inc.
ABBVHealth Care7.44% - 4
Merck & Company Inc
MRKHealth Care5.71% - 5
Roche Ps Par Ag
ROP:SMUnknown4.74% - 6
AstraZeneca PLC
AZN:LNUnknown4.54% - 7
Amgen Inc.
AMGNHealth Care4.29% - 8
Novartis Ag – Class N
NOVN:SMUnknown4.09% - 9
Gilead Sciences
GILDHealth Care3.93% - 10
Pfizer Inc
PFEHealth Care3.47% - 11
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care2.79% - 12
Bristol-Myers Squibb Co.
BMYHealth Care2.73% - 13
Novo Nordisk Class B
NOVOB:COUnknown2.62% - 14
GSK plc
GSK:LNUnknown1.92% - 15
Sanofi
SAN:PAUnknown1.89% - 16
Regeneron Pharmaceuticals, Inc.
REGNHealth Care1.60% - 17
Moderna therapeutics
MRNAHealth Care1.46% - 18
Csl Ltd
CSL:AUUnknown1.28% - 19
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care1.26% - 20
Natera Inc
NTRAHealth Care1.22% - 21
Takeda Pharmaceutical Co. Ltd. Com Stk
4502:JPUnknown1.22% - 22
Bayer (Germany)
BAYGN:SGUnknown1.10% - 23
Teva Pharmaceutical Industries Limited (Adr)
TEVA:ILHealth Care1.01% - 24
Illumina, Inc.
ILMNHealth Care0.90% - 25
Revolution Medicines Inc Ser C Pc Pp
RVMDHealth Care0.81% - 26
Sandoz Group Ag
SDZ:SMHealth Care0.74% - 27
Biogen Inc. Com
BIIBHealth Care0.71% - 28
Otsuka Holdings Co., Ltd. Com Stk
4578:JPUnknown0.65% - 29
Alnylam Pharmaceuticals Inc.
ALNYHealth Care0.64% - 30
Zoetis Inc .
ZTSHealth Care0.63% - 31
Daiichi Sankyo Co. Ltd. Com Stk
4568:JPUnknown0.61% - 32
Ucb Sa
UCB:BRHealth Care0.60% - 33
Astellas Pharma Inc. Com Stk
4503:JPUnknown0.54% - 34
Insmed Inc
INSMHealth Care0.53% - 35
Haleon Plc
HLN:LNUnknown0.53% - 36
Chugai Pharmaceutical Co. Ltd. Com Stk
4519:JPUnknown0.52% - 37
Incyte Corporation Ltd.
INCYHealth Care0.50% - 38
United Therapeutics Corp
UTHRHealth Care0.50% - 39
Royalty Pharma Plc Class A Ordinary Share
RPD:DUFinancials0.49% - 40
Genmab A/S
0MGB:COUnknown0.44% - 41
Viatris
VTRSHealth Care0.43% - 42
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care0.37% - 43
Exelixis Inc
EXELHealth Care0.33% - 44
Neurocrine Biosciences Inc
NBIXHealth Care0.33% - 45
Jazz Pharmaceuticals Plc.
JAZZHealth Care0.33% - 46
Shionogi & Co Ltd
4507:JPUnknown0.27% - 47
Roche Holding Ag- Genusschein
RO:SMHealth Care0.27% - 48
Elanco Animal Health, Inc Cvr
ELANHealth Care0.26% - 49
Biomarin Pharmaceutical Inc.
BMRNHealth Care0.25% - 50
Galderma
GALD:SMUnknown0.24% - 51
Bridgebio Pharma Inc_None_0
BBIOHealth Care0.23% - 52
Dreyfus Trsry Securities Cash Mgmt
DIRXXUnknown0.22% - 53
AUD
Other0.01% - 54
EUR
Other0.00% - 55
Chf
Other0.00% - 56
Cash
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | LLY | 15.460% | ||
| 2 | Johnson & Johnson - Common | JNJ | 9.890% | ||
| 3 | Abbvie Inc. | ABBV | 7.440% | ||
| 4 | Merck & Company Inc | MRK | 5.710% | ||
| 5 | Roche Ps Par Ag | ROP:SM | 4.740% | ||
| 6 | AstraZeneca PLC | AZN:LN | 4.540% | ||
| 7 | Amgen Inc. | AMGN | 4.290% | ||
| 8 | Novartis Ag – Class N | NOVN:SM | 4.090% | ||
| 9 | Gilead Sciences | GILD | 3.930% | ||
| 10 | Pfizer Inc | PFE | 3.470% | ||
| 11 | Nvaesrtex Pharmaceuticals Inc | VRTX | 2.790% | ||
| 12 | Bristol-Myers Squibb Co. | BMY | 2.730% | ||
| 13 | Novo Nordisk Class B | NOVOB:CO | 2.620% | ||
| 14 | GSK plc | GSK:LN | 1.920% | ||
| 15 | Sanofi | SAN:PA | 1.890% | ||
| 16 | Regeneron Pharmaceuticals, Inc. | REGN | 1.600% | ||
| 17 | Moderna therapeutics | MRNA | 1.460% | ||
| 18 | Csl Ltd | CSL:AU | 1.280% | ||
| 19 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 1.260% | ||
| 20 | Natera Inc | NTRA | 1.220% | ||
| 21 | Takeda Pharmaceutical Co. Ltd. Com Stk | 4502:JP | 1.220% | ||
| 22 | Bayer (Germany) | BAYGN:SG | 1.100% | ||
| 23 | Teva Pharmaceutical Industries Limited (Adr) | TEVA:IL | 1.010% | ||
| 24 | Illumina, Inc. | ILMN | 0.900% | ||
| 25 | Revolution Medicines Inc Ser C Pc Pp | RVMD | 0.810% | ||
| 26 | Sandoz Group Ag | SDZ:SM | 0.740% | ||
| 27 | Biogen Inc. Com | BIIB | 0.710% | ||
| 28 | Otsuka Holdings Co., Ltd. Com Stk | 4578:JP | 0.650% | ||
| 29 | Alnylam Pharmaceuticals Inc. | ALNY | 0.640% | ||
| 30 | Zoetis Inc . | ZTS | 0.630% | ||
| 31 | Daiichi Sankyo Co. Ltd. Com Stk | 4568:JP | 0.610% | ||
| 32 | Ucb Sa | UCB:BR | 0.600% | ||
| 33 | Astellas Pharma Inc. Com Stk | 4503:JP | 0.540% | ||
| 34 | Insmed Inc | INSM | 0.530% | ||
| 35 | Haleon Plc | HLN:LN | 0.530% | ||
| 36 | Chugai Pharmaceutical Co. Ltd. Com Stk | 4519:JP | 0.520% | ||
| 37 | Incyte Corporation Ltd. | INCY | 0.500% | ||
| 38 | United Therapeutics Corp | UTHR | 0.500% | ||
| 39 | Royalty Pharma Plc Class A Ordinary Share | RPD:DU | 0.490% | ||
| 40 | Genmab A/S | 0MGB:CO | 0.440% | ||
| 41 | Viatris | VTRS | 0.430% | ||
| 42 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 0.370% | ||
| 43 | Exelixis Inc | EXEL | 0.330% | ||
| 44 | Neurocrine Biosciences Inc | NBIX | 0.330% | ||
| 45 | Jazz Pharmaceuticals Plc. | JAZZ | 0.330% | ||
| 46 | Shionogi & Co Ltd | 4507:JP | 0.270% | ||
| 47 | Roche Holding Ag- Genusschein | RO:SM | 0.270% | ||
| 48 | Elanco Animal Health, Inc Cvr | ELAN | 0.260% | ||
| 49 | Biomarin Pharmaceutical Inc. | BMRN | 0.250% | ||
| 50 | Galderma | GALD:SM | 0.240% | ||
| 51 | Bridgebio Pharma Inc_None_0 | BBIO | 0.230% | ||
| 52 | Dreyfus Trsry Securities Cash Mgmt | DIRXX | 0.220% | ||
| 53 | AUD | - | 0.010% | ||
| 54 | EUR | - | 0.000% | ||
| 55 | Chf | - | 0.000% | ||
| 56 | Cash | - | 0.000% |

































